TrialArchives of dermatological research2023
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.
Daniela Mikhaylov et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it